Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Changed, over the years?

There has been a significant increase in the market size of chemotherapy-induced nausea and vomiting (CINV) in the past years. Anticipated growth from $2.92 billion in 2024 to $3.15 billion in 2025, translating to a compound annual growth rate (CAGR) of 7.9%, is predicted. Factors such as the escalating use of chemotherapy, enhanced antiemetic agents, developed clinical guidelines, and patient advocacy are credited for the growth witnessed in the historical period.

How Much Will the Chemotherapy-Induced Nausea and Vomiting (CINV) Market Be Worth in 2029?

The market size for chemotherapy-induced nausea and vomiting (CINV) is anticipated to witness significant growth in the upcoming years. The CINV market size is projected to reach $4.2 billion in 2029, with a compound annual growth rate (CAGR) of 7.5%. This projected growth in the forecast period is due to factors such as personalized medicine, the progress in antiemetic agents, telehealth and remote monitoring, and health equity initiatives. Key trends expected during the forecast period encompass combined antiemetic therapies, supportive care services, digital health instruments, and survivorship care.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13031&type=smp

Which is the Largest Company in the Chemotherapy-Induced Nausea and Vomiting (CINV) Market?

Major companies operating in the chemotherapy-induced nausea and vomiting (cinv) market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Novartis AG, AstraZeneca PLC, GlaxoSmithKline PLC, Baxter International Inc., Teva Pharmaceuticals Industries Ltd., Bausch Health Companies Inc., Eisai Co. Ltd., Jazz Pharmaceuticals PLC, Ono Pharmaceutical Co. Ltd., Dr. Reddy’s Laboratories Ltd., Kyowa Kirin Inc., Amneal Pharmaceuticals Inc., Mundipharma International Limited, Insys Therapeutics Inc., Lupin Limited, Helsinn Holding S.A., Heron Therapeutics Inc., Camurus AB, Cadila Pharmaceuticals Limited, Acacia Pharma Ltd., Soligenix Inc.

What Are the Main Market Drivers in the Chemotherapy-Induced Nausea and Vomiting (CINV) Industry?

As cancer rates continue to rise, it is anticipated that the chemotherapy-induced nausea and vomiting (CINV) market will likewise experience growth. Cancer occurs when cells develop without restraint and spread throughout the body. The rising occurrence of cancer has prompted a stronger drive towards devising more potent and specific anti-emetic therapies to manage CINV, a bothersome by-product of chemotherapy treatment. The intensified attention towards managing CINV has contributed to progress in comprehending its causative biological processes and crafting new treatments. The American Cancer Society, a volunteer health group devoted to eliminating cancer in the U.S, reported that by January 2023, there would approximately be 1.9 million new cancer cases and 609,820 cancer-related deaths. Consequently, the mounting prevalence of cancer is expected to stimulate the chemotherapy-induced nausea and vomiting (CINV) market.

Chemotherapy-Induced Nausea and Vomiting (CINV) Market Driver: Regulatory Initiatives Contribute to Market Growth

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13031&type=smp

How Is the Chemotherapy-Induced Nausea and Vomiting (CINV) Market Segments Structured?

The chemotherapy-induced nausea and vomiting (CINV) market covered in this report is segmented –

1) By Form: Injectables, Oral, Transdermal Patches

2) By Drug Class: 5-HT3 Receptor Antagonists, Neurokinin-1 Receptor Antagonists, Corticosteroids, Cannabinoids, Other Drug Class

3) By Emetogenic Risk: Highly Emetogenic Chemotherapy (HEC), Moderately Emetogenic Chemotherapy (MEC), Low Emetogenic Chemotherapy (LEC)

4) By Distribution Channel: CINV Hospitals, Cancer Research Institute, Retail Pharmacies, Online Pharmacies, Drug Stores

5) By Application: Gynecology, Urology, Gastrointestinal Surgery, Other Applications

Subsegments:

1) By Injectables: Intravenous (IV) Solutions, Intramuscular (IM) Injections

2) By Oral: Tablets, Capsules, Liquid Formulations

3) By Transdermal Patches: Fentanyl Patches, Scopolamine Patches

What Strategic Trends Are Transforming the Chemotherapy-Induced Nausea and Vomiting (CINV) Market?

In the chemotherapy-induced nausea and vomiting (CINV) industry, key players are adopting strategies such as launching new products with advanced features like fixed intravenous antiemetic to hold a competitive edge. This term signifies a medication that is given through an IV at a prespecified dose to alleviate or prevent nausea and vomiting, a common occurrence post surgery or during chemotherapy. For instance, Glenmark Pharmaceuticals Limited, a producer of pharmaceuticals, generic drugs, and consumer health products based in India, rolled out AKYNZEO I.V. in India in January 2023, marking the first appearance of a fixed intravenous antiemetic combo produced for CINV prevention. The product blends netupitant and palonosetron, offering a treatment for both immediate and delayed instances of nausea and vomiting. It offers the convenience of a single dose, enhancing complete response rates and improving quality of life for individuals with cancer. Clinical research suggests its efficacy is especially noteworthy for patients undergoing highly emetogenic chemotherapy.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-nausea-and-vomiting-cinv-global-market-report

Which Global Regions Offer the Highest Growth in the Chemotherapy-Induced Nausea and Vomiting (CINV) Market?

North America was the largest region in the chemotherapy-induced nausea and vomiting (CINV) market in 2024. The regions covered in chemotherapy-induced nausea and vomiting (CINV) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13031

This Report Delivers Insight On:

1. How big is the chemotherapy-induced nausea and vomiting (cinv) market, and how is it changing globally?

2. Who are the major companies in the chemotherapy-induced nausea and vomiting (cinv) market, and how are they performing?

3. What are the key opportunities and risks in the chemotherapy-induced nausea and vomiting (cinv) market right now?

4. Which products or customer segments are growing the most in the chemotherapy-induced nausea and vomiting (cinv) market?

5. What factors are helping or slowing down the growth of the chemotherapy-induced nausea and vomiting (cinv) market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model